{
  "chapter": "Cvs Pharmacology-Previous Year Questions",
  "questions": [
    {
      "q_no": 1,
      "question": "Which of the following thiazide diuretics is appropriate for a 34-year-old man with hypertension and stage 4 chronic kidney disease, characterized by an estimated glomerular filtration rate (eGFR) below 30?",
      "options": {
        "A": "Chlorothiazide",
        "B": "Chlorthalidone",
        "C": "Metolazone",
        "D": "Hydrocholorothiazide"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer C - Metolazone Metolazone can be used to treat hypertension in patients with chronic kidney disease. In patients with chronic renal failure, thiazide diuretic is not effective, but Metolazone is an exception as it is effective as aan ntihypertensive medication in patients with chronic renal failure. It works by inhibiting the reabsorption of sodium and water in the kidneys, which leads to increased urine production and decreased blood volume. It also has an additional action in the PCT, as thiazides mainly act on the DCT. It is less likely to cause electrolyte imbalances compared to other thiazide diuretics. Chlorothiazide (Option A), Chlorthalidone (Option B) and Hydrochlorothiazide (Option D) are a thiazide diuretic that works by increasing the excretion of sodium and water in the urine, which leads to a decrease in blood volume and blood pressure. However, in patients with severe CKD, such as stage 4, thiazide diuretics may be less effective as the kidneys are not able to excrete sodium and water as efficiently, and the risk of electrolyte imbalances may also be higher. Reference: K.D Tripathi - Essentials of medical pharmacology, 8th Edition, Page 630-632",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 2,
      "question": "A patient with a history of hypertension is given the drug ‘X’. Identify ‘X’?",
      "options": {
        "A": "Captopril",
        "B": "Spironolactone",
        "C": "Aliskiren",
        "D": "Losartan"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer C - Aliskiren The drug marked ‘X’ is Aliskiren . Class: Renin inhibitor Mechanism: It works by inhibiting renin, blocking the production of angiotensin I, and lowering blood pressure. Use: Treatment of hypertension. Captopril (Option A) is an angiotensin-converting enzyme (ACE) inhibitor. It inhibits the activity of ACE (an enzyme responsible for converting angiotensin I into angiotensin II), reducing the production of angiotensin II (vasoconstrictor). This results in vasodilation decreased peripheral resistance, and lower blood pressure. It is commonly used for the treatment of hypertension and heart failure. Spironolactone (Option B) is a potassium-sparing diuretic and aldosterone receptor antagonist. It binds to the aldosterone receptors (kidneys and other tissues) and inhibits the effects of aldosterone, promoting sodium and water excretion while retaining potassium, leading to diuresis. It is used in the treatment of hypertension, heart failure, and certain hormonal disorders. Losartan (Option D) is an angiotensin II receptor antagonist targeting the angiotensin II type 1 (AT1) receptors. It selectively blocks these receptors, preventing the binding of angiotensin II resulting in vasodilation and a decrease in peripheral resistance and blood pressure. It is commonly prescribed for the management of hypertension and heart failure.",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpharmacology/Cvs_Pharmacology-Previous_Year_Questions_Q2_q.png",
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 3,
      "question": "Which drug elicits the following response on blood pressure and heart rate, as shown in the image?",
      "options": {
        "A": "Norepinephrine",
        "B": "Isoproterenol",
        "C": "Epinephrine",
        "D": "Dopamine"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer A - Norepinephrine The image illustrates an elevation in arterial blood pressure and a reduction in heart rate, which are effects associated with Norepinephrine, which increases systolic, diastolic, and mean arterial pressure and causes reflex bradycardia. Description Norepinephrine, or noradrenaline, is a sympathomimetic drug used primarily as a vasopressor. Mechanism of Action (MOA) It acts on α 1 and β 1 adrenergic receptors and has some affinity for alpha-2 receptors. Activation of α 1 receptors causes vasoconstriction, increasing peripheral resistance and blood pressure. Activation of β 1 receptors increases heart rate and myocardial contractility. Uses Treatment of acute hypotension (e.g., septic shock, cardiogenic shock). Cardiac arrest. Side effects Cardiovascular: Arrhythmias, bradycardia, hypertension. CNS: Anxiety, headache, tremor. Gastrointestinal: Nausea, vomiting. Respiratory: Respiratory difficulty, dyspnea. Metabolic: Hyperglycemia, lactic acidosis. Contraindications Peripheral vascular thrombosis (risk of ischemia). During anesthesia with cyclopropane or halothane (due to the risk of arrhythmias). Hypotension is due to blood volume deficits (hypovolemia) until an adequate fluid replacement. Isoproterenol (Option B) is a sympathomimetic drug that causes beta-2 mediated vasodilation and leads to a decrease in mean blood pressure and increased heart rate. Epinephrine (Option C) increases heart rate and blood pressure at lower doses by stimulating beta-1 adrenergic receptors in the heart, but at higher doses, there is a rise in blood pressure, but later beta-2 action predominates and leads to a decrease in blood pressure (biphasic reaction). Dopamine (Option D) can increase or decrease blood pressure and heart rate depending on the dose and the type of receptors it stimulates. At low doses, it stimulates mainly dopaminergic receptors in the kidneys, causing vasodilation and increasing renal blood flow. At the same",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpharmacology/Cvs_Pharmacology-Previous_Year_Questions_Q3_q.png",
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 4,
      "question": "Which of the following is the false statement regarding statins? there is a mild increase in lipoprotein a (Lpa) levels.",
      "options": {
        "A": "Although HMG-CoA reductase inhibitors substantially reduce the risk of cardiovascular events,",
        "B": "These drugs should not be stopped even in severe conditions like injury, surgery etc.",
        "C": "They can be given with verapamil and other enzyme inhibitors",
        "D": "With long-term use, there is a slight increase in the incidence of type 2 diabetes mellitus."
      },
      "correct_answer": "C",
      "explanation": "reductase, which is responsible for the synthesis of cholesterol in the liver. They are widely used to reduce the risk of cardiovascular events such as heart attack and stroke. Statins should not be given with verapamil, as it is a cytochrome 3A4 enzyme inhibitor that can increase the levels of statins in the blood, leading to increasing risk of myopathy. Although HMG-CoA reductase inhibitors substantially reduce the risk of cardiovascular events, there is a mild increase in lipoprotein a (Lpa) levels (Option A): It is a true statement regarding statins. It is well established that statins substantially reduce the risk of cardiovascular events. However, there are a mild increase in lipoprotein (Lpa) levels, which is a risk factor for cardiovascular disease. These drugs should not be stopped even in severe conditions like injury, surgery etc (Option B): Statins should not be stopped abruptly, even in severe conditions such as injury or surgery, as it can increase the risk of cardiovascular events. With long-term use, there is a slight increase in the incidence of type 2 diabetes mellitus (Option C): Long-term use of statins has been associated with a slight increase in the risk of developing type 2 diabetes mellitus . This risk is modest and primarily affects those who are already at risk (e.g., people with metabolic syndrome or prediabetes). The cardiovascular benefits of statins, however, far outweigh this small increase in diabetes risk. Reference: Goodman and Gilman’s Pharmacological Basis of Therapeutics, 14th Edition, Pages 734,38,39",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 5,
      "question": "Identify the correct match, regarding the drug and its adverse effect.:",
      "options": {
        "A": "Hydralazine - heart failure",
        "B": "Atenolol - hemolytic anemia",
        "C": "Aliskiren - hypokalemia",
        "D": "Verapamil - Constipation"
      },
      "correct_answer": "D",
      "explanation": "arrhythmias. One of the most common gastrointestinal side effects of verapamil is constipation. It works by blocking the influx of calcium ions into smooth muscle cells, which reduces the force of contraction and dilates the blood vessels. This is thought to occur because verapamil can slow down the contractions of the intestinal muscles, l eading to reduced motility and increased transit time. Other gastrointestinal side effects of verapamil may include nausea, vomiting, abdominal discomfort and diarrhea. Hydralazine - heart failure (Option A) : Hydralazine is a vasodilator that is used to treat hypertension and heart failure. It works by relaxing the smooth muscle cells in the blood vessels, which reduces peripheral resistance and increases blood flow to the heart. Hydralazine is not known to cause heart failure; it may be used to treat heart failure in certain patients. Atenolol - hemolytic anemia (Option B) : Atenolol is a beta-blocker used to treat hypertension, angina, and certain arrhythmias. It works by blocking the action of the beta-adrenergic receptors, which reduces the heart rate and cardiac output. Hemolytic anemia is not a known side effect of atenolol. Aliskiren - hypokalemia (Option C) : Aliskiren is a direct renin inhibitor used to treat hypertension. It works by blocking the activity of renin, an enzyme that plays a key role in regulating blood pressure. Hypokalemia (low potassium levels in the blood) is not a known side effect of aliskiren. Aliskiren can, however, cause other electrolyte imbalances, such as hyperkalemia (high potassium levels in the blood). Reference: NIH Link Goodman & Gillman’s Pharmacological Basis of Therapeutics, 14th Edition, Page 652 Medscape Link , Link .",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 6,
      "question": "An anti–arrhythmic drug is shown to have the following effect. It is effective in both atrial and ventricular arrhythmias. Identify the drug.",
      "options": {
        "A": "Tocainide",
        "B": "Propranolol",
        "C": "Quinidine",
        "D": "Lignocaine"
      },
      "correct_answer": "C",
      "explanation": "arrhythmias. It works by blocking sodium channels, which leads to decreases in the influx of sodium ions during the depolarization phase of the cardiac action potential. This leads to a reduction in the conduction velocity and prolongation of the refractory period in cardiac tissues, helping to suppress abnormal electrical impulses and arrhythmias. Tocainide (Option A) is also a sodium channel blocker that belongs to class 1b antiarrhythmics ,and it is used to treat only ventricular tachycardia. Propranolol (Option B) is a non-selective beta-blocker and belongs to class 2 antiarrhythmics, it is used in chronic treatment to prevent arrhythmias in Long QT Syndrome (LQTS) and Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT). It is also used in Atrial Fibrillation, but is not as effective as quinidine in treating ventricular arrhythmias. Lignocaine (Option D) is also a Class 1b antiarrhythmi c that is primarily effective in treating ventricular arrhythmias, but It is not typically used for atrial arrhythmias. Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition Page 680.",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpharmacology/Cvs_Pharmacology-Previous_Year_Questions_Q6_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 7,
      "question": "Match the following antiarrhythmic drugs with their mechanism of action: Mechanism of action Drug Na + channel blocker K + channel blocker Na + , K + ATPase inhibitor Beta-blocker Quinidine Digoxin Esmolol Ibutilde",
      "options": {
        "A": "1-d, 2-b, 3-a, 4-c",
        "B": "1-a, 2-c, 3-d, 4-b",
        "C": "1-a, 2-d, 3-b, 4-c",
        "D": "1-d, 2-c, 3-a, 4-b"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) 1-a, 2-d, 3-b, 4-c Explanation: Drug MOA Quinidine Is a Na + channel blocker, which is a class I antiarrhythmic drug that acts by blocking sodium channels in the cardiac cells. By blocking these channels, it decreases the influx of sodium ions during the depolarization phase of the cardiac action potential. Digoxin It is a Na + K + ATPase inhibitor, which is not primarily considered an antiarrhythmic drug but rather a cardiac glycoside. However, it does have some antiarrhythmic effects. Digoxin inhibits the activity of the Na + K + ATPase pump , and increases intracellular calcium levels , leading to increased contractility of the heart. This indirectly helps to control certain arrhythmias, such as atrial fibrillation Esmolol It belongs to the class of beta-blockers , specifically a short-acting selective beta-1 adrenergic receptor blocker. It works by blocking the beta-1 adrenergic receptors in the heart, thereby reducing the effects of sympathetic stimulation. Ibutilide It is a potassium channel blocker, which is a class III antiarrhythmic drug that primarily blocks potassium channels in the heart. By inhibiting these channels, it prolongs the repolarization phase of the cardiac action potential, resulting in an increase in the action potential duration and effective refractory period. Reference: Goodman and Gilman’s Pharmacological Basis of Therapeutics, 14the Edition, Page 680",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 8,
      "question": "Which of the medications listed below is considered safe for the treatment of pregnancy-induced hypertension?",
      "options": {
        "A": "Lisinopril",
        "B": "Propranolol",
        "C": "Alpha methyldopa",
        "D": "Losartan"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer C - Alpha methyldopa Alpha methyldopa is considered the drug of choice for treating pregnancy-induced hypertension (gestational hypertension). It is a centrally acting alpha-2 adrenergic agonist that has a well-established safety profile in pregnancy. Antihypertensives in Pregnancy DOC: Labetaolol (Beta-blocker) If chronic hypertension develops, Alpha methyldopa Safe antihypertensives during pregnancy Labetalol, Hydralazine, Methyldopa, and Calcium channel blockers like Nifedipine. (LHMC- Lady Hardinge Medical College) Unsafe antihypertensive drugs during pregnancy: ACE inhibitors (Option A) & ARBs (Option D): Can lead to renal agenesis in the fetus, causing oligohydramnios and leading to POTTER sequence (Pulmonary hypoplasia, Oligohydramnios, Twisted/wrinkled skin, Twisted Potter faces, Extremity defects, Renal agenesis). Thiazides/Loop diuretics/Beta-blockers (Option B): Bear the risk of placental ischemia , which can be fatal to the fetus. Reference: K D Tripathi, Essentials of Medical Pharmacology, 8th Edition, Page 615-617",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 9,
      "question": "A patient presents to the OPD with a chronic dry cough with no fever or other associated symptoms. He had recently been started on an antihypertensive for hypertension. Which among the following is most likely responsible for causing these symptoms?",
      "options": {
        "A": "Bradykinin and renin",
        "B": "Angiotensin II and bradykinin",
        "C": "Only bradykinin",
        "D": "Histamine"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer C - Only bradykinin Bradykinin is a key factor in the development of a chronic dry cough, which is a common side effect of angiotensin-converting enzyme inhibitors (ACE inhibitors) . ACE inhibitors, such as enalapril or lisinopril , increase bradykinin levels due to inhibition of the enzyme that normally breaks it down. Accumulation of bradykinin in the respiratory tract can trigger a persistent dry cough.The management of cough involves switching to an alternative antihypertensive medication, such as an angiotensin II receptor blocker (ARB) , which does not affect bradykinin metabolism and is less likely to induce cough. Adverse effects of ACEI: Adverse Effect Description Hypotension Decrease in blood pressure, especially upon initiation of therapy or with dosage increases. Hyperkalemia Increased serum potassium levels due to reduced aldosterone secretion. Cough Persistent dry cough, possibly due to bradykinin buildup in the lungs. Angioedema Due to increased bradykinin levels, swelling of deeper layers of skin, particularly around the eyes and lips, can be life-threatening. Rashes/Urticaria Skin reactions like rashes or hives occur in a small percentage of users. Dysgeusia Reversible taste changes are more common with captopril . Rare Effects Granulocytopenia (low white blood cells) and proteinuria (excess protein in urine) are more concerning in patients with kidney disease. Acute Renal Failure Possible in patients with bilateral renal artery stenosis due to decreased kidney filtration. Fetal Effects ACE inhibitors are contraindicated during pregnancy due to potential harm to the fetus, including fetal renal damage due to inhibition of the fetal renin-angiotensin system. Reference: K D Tripathi, Essentials of Medical Pharmacology, 8th Edition, Page 531",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 10,
      "question": "In patients with indications for warfarin usage, what is the recommended range of INR in a patient with mechanical heart valves?",
      "options": {
        "A": "1.0-1.5",
        "B": "2.0-3.0",
        "C": "2.5-3.5",
        "D": "3.5-4.5"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer C - 2.5-3.5 The recommended International Normalized Ratio (INR) range for patients with mechanical heart valves is typically 2.5 to 3.5 . This range helps to balance the risk of thromboembolism (clot formation) and bleeding complications associated with warfarin therapy. Warfarin therapy is monitored using prothrombin time, as it is sensitive to reductions in prothrombin, factor VII, and factor X levels. The International Normalized Ratio (INR) is used to standardize prothrombin time results. 1.0-1.5 (Option A): This INR range is too low to achieve the desired therapeutic effect of warfarin. 2.0-3.0 (Option B): For patients on regular warfarin therapy, the recommended INR range is typically between 2.0 and 3.0. 3.5-4.5 (Option D): An INR above 3.5 is generally not recommended, as it significantly increases the risk of bleeding. Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Page 934 Goodman and Gilman, Pharmacologic Basis of Therapeutics, 13th Edition, Page 593",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 11,
      "question": "What is the preferred medication for managing ventricular arrhythmia caused by digoxin?",
      "options": {
        "A": "Procainamide",
        "B": "Lignocaine",
        "C": "Atropine",
        "D": "Propranolol"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer B - Lignocaine Lignocaine (Lidocaine) is the preferred drug for managing ventricular arrhythmias caused by digoxin toxicity. It is a Class 1b antiarrhythmic that stabilises the cardiac membrane and inhibits abnormal electrical impulses. Procainamide (Option A) is a Class 1A antiarrhythmic drug primarily used to manage arrhythmias such as Wolff-Parkinson-White syndrome , supraventricular arrhythmias, atrial flutter, atrial fibrillation, and AV nodal reentrant tachycardia. However, it is not the first-line treatment for ventricular arrhythmias caused by digoxin toxicity. Atropine (Option C) is an anticholinergic medication used primarily to treat bradycardia. It can also be utilized in the treatment of diarrhea, as it helps reduce gastrointestinal motility. However, it is not effective for treating arrhythmias caused by digoxin toxicity. Propranolol (Option D) is a non-selective beta-blocker used to treat various conditions such as high blood pressure, tremors, and irregular heartbeats and to prevent migraines. While effective for managing certain cardiac conditions, it is not recommended for managing ventricular arrhythmias induced by digoxin, as it may exacerbate the toxicity. Reference: Goodman and Gilman, Pharmacologic Basis of Therapeutics, 14th Edition, Page 538-540",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 12,
      "question": "A 57-year-old man was brought to the hospital with complaints of dizziness and breathlessness. During the physical examination, his face appears to be discoloured. His current medication includes Amiodarone, Metoprolol, Verapamil, Lisinopril and Amlodipine. Which of the following drugs is responsible for these skin changes?",
      "options": {
        "A": "Amiodarone",
        "B": "Amlodipine",
        "C": "Metoprolol",
        "D": "Verapamil"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Amiodarone Explanation: The grey-blue discolouration over this patient's face is most likely due to Amiodarone. Long-term treatment with amiodarone is responsible for skin pigmentation. Ultraviolet light reacts with amiodarone and its metabolites to cause local vasodilatation. This increases the diffusion of amiodarone and its metabolites, resulting in their deposition in the tissues and causing pigmentation. It is usually seen in sun-exposed areas ,and elderly men are at an increased risk. Cessation of amiodarone and avoiding exposure to sunlight using sunscreen cream is recommended. Amiodarone MOA Prolonged action potential duration and QT interval by blocking delayed rectifier K+ channels. Blocks inactivated Na+ channels, with rapid channel recovery (Decrease phase 0 slope). Partially inhibits myocardial Ca2+ channels, adding to its antiarrhythmic effects. Used to treat both atrial and ventricular fibrillation Uses To maintain normal sinus rhythm during atrial fibrillation and prevent recurrent ventricular tachycardia. Adverse effects Hypotension and Bradycardia (with i.v administration or after drug accumulation) Photosensitivity: Skin pigmentation - Purple colour (purple man syndrome, smurf syndrome) Corneal microdeposits: Reversible upon drug discontinuation.",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpharmacology/Cvs_Pharmacology-Previous_Year_Questions_Q12_q.png",
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 13,
      "question": "What is the half-life of digoxin?",
      "options": {
        "A": "12 hours",
        "B": "24 hours",
        "C": "36 hours",
        "D": "48 hours"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) 36 hours Explanation: The half-life of digoxin is approximately 36 hours . This means that it takes about 36 hours for the plasma concentration of digoxin to reduce by half in the body. Since digoxin is primarily eliminated by the kidneys (about 80%), the half-life can be prolonged in patients with impaired renal function. Digoxin: Inotropic Action: Increases intracellular Ca² I , improving heart failure and causing arrhythmias in overdose. Utility: Controls ventricular rate in atrial fibrillation (AF) and terminates reentrant arrhythmias, especially in heart failure patients. Adverse Effects: Toxicity: Common due to low therapeutic index. Symptoms include nausea, cognitive disturbances, blurred/yellow vision, and arrhythmias. Arrhythmias: Includes atrial tachycardia with AV block, ventricular bigeminy, bidirectional VT, and AV block. Severe Toxicity: Hyperkalemia, bradyarrhythmias, and potential unresponsiveness to pacing therapy. Half-Life: 36 hours , with renal elimination as the primary route (80%). Drug Interactions: Drugs like amiodarone, quinidine, and diuretics increase the risk of toxicity by altering digoxin clearance or causing electrolyte imbalances. Reference: Goodman and Gilman's Pharmacological Basis of Therapeutics, 14th Edition, Page 687",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 14,
      "question": "Inhaled Nitric oxide is approved for the treatment of?",
      "options": {
        "A": "Labile hypertension",
        "B": "Pulmonary hypertension",
        "C": "Treatment of resistant migraine",
        "D": "Resistant Parkinson’s disease"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer B - Pulmonary hypertension Inhaled Nitric Oxide is approved for the treatment of Pulmonary hypertension. In pulmonary hypertension, the pulmonary arteries become narrowed or blocked. Making it harder for blood to flow through them thus increasing the blood pressure within the pulmonary arterial circulation The only FDA-approved medical therapeutic indication of Nitric Oxide is persistent pulmonary hypertension in newborns. Nitric Oxide Inhaled nitric oxide is a gas that is used to treat pulmonary hypertension because it acts as a potent vasodilator, meaning it relaxes the smooth muscle in the walls of the pulmonary arteries and improves blood flow. MOA Activation of guanylate cyclase, which converts guanosine triphosphate (GTP) to cyclic guanosine monophosphate (cGMP) cGMP causes relaxation of the smooth muscle cells in the pulmonary arteries, leading to vasodilation of the vessels Uses Therapeutic indication Pulmonary arterial hypertension Rescue therapy for severely hypoxemic patients Diagnostic indication To evaluate pulmonary reactivity during cardiac catheterisation. To determine diffusion capacity across the alveolar-capillary unit. Adverse effects Headache, nausea and vomiting Methemoglobinemia It may worsen left ventricular performance in those with impaired ventricular function. Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition, Page 401",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpharmacology/Cvs_Pharmacology-Previous_Year_Questions_Q14_exp.jpg",
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 15,
      "question": "A 35-year-old chronic hypertensive woman comes to the OPD for preconception counselling. Which of the following antihypertensives should be discontinued in this patient?",
      "options": {
        "A": "Labetalol",
        "B": "Calcium channel blocker",
        "C": "Angiotensin-converting enzyme inhibitor",
        "D": "Alpha - methyldopa"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Angiotensin-converting enzyme inhibitor Explanation: Angiotensin-converting enzyme inhibitors (ACEI) should be discontinued in women planning for pregnancy or immediately upon confirmation of pregnancy, as they are teratogenic and associated with risks of fetal malformations, growth retardation, renal agenesis, and reduced amniotic fluid levels. Antihypertensives in pregnancy To be used To be avoided Labetalol ( α + β receptor antagonist) Nifedipine (Calcium channel blocker *) α - Methyldopa Hydralazine Thiazides can be used in chronic hypertension in pregnant women ACEi and ARB - teratogenic Diuretic - reduces uteroplacental perfusion Non-selective beta-blocker * CCB can be useful in preeclampsia, but they must be stopped before labour as they can weaken uterine contractions Reference: K D Tripathi, Essentials of Medical Pharmacology, 8th Edition, Page 100, 531, 617, 618 Williams Obstetrics, 24th Edition, Page 247, 1005",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 16,
      "question": "A patient who was recently started on an antihypertensive presented with the following presentation, as shown in the image below. Which of the following antihypertensive medications was most likely prescribed to him?",
      "options": {
        "A": "Lisinopril",
        "B": "Nifedipine",
        "C": "Atenolol",
        "D": "Clonidine"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Lisinopril Explanation: Based on the history and clinical presentation, this patient is most likely suffering from angioedema, which is associated with Lisinopril, an angiotensin-converting enzyme inhibitor. It presents with swelling of the face, lips, tongue, throat and extremities. Although rare, it is a serious allergic reaction that requires immediate medical attention. It is treated with antihistamines and corticosteroids. If laryngospasm has occurred, subcutaneous injection of epinephrine can be used. Adverse effects of angiotensin-converting enzyme inhibitors Hypotension Decrease in blood pressure, especially upon initiation of therapy or with dosage increases. Hyperkalemia Increased serum potassium levels due to reduced aldosterone secretion. Cough Persistent dry cough, possibly due to bradykinin buildup in the lungs. Angioedema Due to increased bradykinin levels, swelling of deeper layers of skin, particularly around the eyes and lips, can be life-threatening. Rashes/Urticaria Skin reactions like rashes or hives occur in a small percentage of users.",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpharmacology/Cvs_Pharmacology-Previous_Year_Questions_Q16_q.png",
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 17,
      "question": "Which anti-hypertensive medication is suitable for administration to a patient suffering from renal insufficiency, exhibiting symptoms of significantly reduced urine output, pedal edema, headache, and a blood pressure reading of 160/90?",
      "options": {
        "A": "Aliskiren",
        "B": "Chlorthalidone",
        "C": "Amlodipine",
        "D": "Prazosin"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Amlodipine Explanation: Based on the clinical presentation and findings in this patient, the most appropriate anti-hypertensive drug would be Amlodipine. Calcium channel blockers achieve better blood pressure control in the long term. It can be used as an add-on therapy with other antihypertensive agents, and its once-daily dosing improves patient compliance. Amlodipine is often well-tolerated and can be used in patients with renal insufficiency. Mechanism of action of CCB (Dihydropyridines): It blocks the entry of calcium ions through the L-type calcium channels in vascular smooth muscle cells, causing vasodilation and a reduction in peripheral vascular resistance. Drug Use Rationale for Choice Nifedipine (Short-acting) Primarily used for angina pectoris. It is not recommended for long-term hypertension management due to its short duration of action and potential for reflex tachycardia . Nicardipine (Short-acting) It is commonly used in the management of hypertensive emergencies and perioperative hypertension or severe hypertension in the intensive care unit. The short duration of action makes it less suitable for long-term hypertension management. Clevidipine (Ultra-short-acting) Very short half-life makes it unsuitable for long-term hypertension management. Amlodipine (Long-acting) Recommended as a first-line or add-on therapy for the long-term management of hypertension. Preferred choice due to its long duration of action (up to 24 hours), once-daily dosing, and effectiveness in lowering blood pressure with good tolerability. Aliskiren (Option A) is a direct renin inhibitor that can be used to treat hypertension. However, it is generally not recommended in patients with renal insufficiency, as it can further decrease kidney function. Chlorthalidone (Option B) is a thiazide-like diuretic that is often used to treat hypertension. However, in a patient with very low urine output and pedal edema, adding a diuretic may not be the initial choice, as it may exacerbate fluid and electrolyte imbalances. Prazosin (Option D) is an alpha-1 adrenergic blocker that is used to treat high blood pressure. However, in this scenario, with symptoms of renal insufficiency and very low urine output, the focus should be on addressing the underlying renal issue and controlling blood pressure with other medications. Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition, Page 516 K D Tripathi, Essentials of Medical Pharmacology, 8th Edition, Page 530, 610",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 18,
      "question": "Which of the following side effects are likely to be observed when a patient already taking metoprolol is prescribed verapamil? a) Bradycardia with Av Block b) Torsades De Pointes c) Tachycardia d) Ventricular Fibrillation",
      "options": {
        "A": "a only",
        "B": "a & b",
        "C": "a & c",
        "D": "b & d"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer A - a only Metoprolol (a beta-blocker) and verapamil (a calcium channel blocker) negatively affect heart rate and AV conduction. When used together, they can cause bradycardia (slow heart rate) and AV block , which can be dangerous. Torsades de pointes (Option B) is a type of ventricular tachycardia with a distinct ECG pattern. Although both metoprolol and verapamil can influence cardiac conduction, their combination is not typically linked to the development of torsades de pointes. Tachycardia (Option C): Both metoprolol and verapamil have negative chronotropic effects, meaning they lower the heart rate. As a result, combining these drugs is unlikely to cause tachycardia (an increased heart rate). Ventricular fibrillation (Option D) is a severe, life-threatening arrhythmia marked by rapid, irregular ventricular contractions. While both metoprolol and verapamil affect heart conduction, their combination is not commonly associated with ventricular fibrillation. Reference: K D Tripathi, Essentials of Medical Pharmacology, 8th Edition, Page 146,59",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 19,
      "question": "Which of the following drugs acts by inhibiting the late sodium current in the heart?",
      "options": {
        "A": "Ivabradine",
        "B": "Ranolazine",
        "C": "Trimetazidine",
        "D": "Fasudil"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Ranolazine Explanation: Ranolazine acts by inhibiting the late sodium current in the heart. Ranolazine MOA Inhibits the late sodium current in cardiomyocytes, which helps to reduce intracellular sodium accumulation during ischemic conditions Indirectly reduces calcium overload in cardiac cells and improves myocardial relaxation, leading to an anti-ischemic effect. It decreases ventricular diastolic tension, reduces myocardial oxygen consumption, and improves myocardial perfusion Uses Used as add-on therapy as an Antianginal agent for Chronic stable angina. Reduces the frequency of angina pectoris and improves exercise tolerance. Ventricular tachycardia. Improves glycemic control (lower HbA1c and increase insulin) Adverse effect Dizziness, headache, nausea and asthenia Constipation and Liver failure QT-prolongation and rarely Ventricular arrhythmia such as Torsades de pointes. Ivabradine (Option A) acts as a selective inhibitor of the pacemaker if it is current in the sinoatrial node, leading to heart rate reduction. It is primarily used for the treatment of stable angina and heart failure with reduced ejection fraction. Trimetazidine (Option C) is a metabolic agent that improves myocardial energy metabolism by enhancing glucose oxidation and reducing fatty acid oxidation. It does not directly inhibit the late sodium current. Fasudil (Option D) is a calcium channel blocker that primarily acts by inhibiting Rho-kinase, an enzyme involved in regulating smooth muscle contraction. It is mainly used for the treatment of cerebral vasospasm after subarachnoid haemorrhage and is not directly related to inhibiting the late sodium current in the heart. Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition, Page 618-620",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 20,
      "question": "Which of the following antiarrhythmic drugs is contraindicated in a patient with interstitial lung disease?",
      "options": {
        "A": "Amiodarone",
        "B": "Sotalol",
        "C": "Quinidine",
        "D": "Lignocaine"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer A - Amiodarone Explanation: Amiodarone is contraindicated in a patient with interstitial lung disease. It is a class III antiarrhythmic medication that is associated with the development or exacerbation of interstitial lung disease, a condition characterised by inflammation and scarring of lung tissue. Side effects of amiodarone: Pulmonary fibrosis Hypotension Torsades de pointes Corneal microdeposits Hepatotoxicity Neuropathy Photosensitivity Thyroid dysfunction Drugs associated with Lung disorders: Drugs Lung disorders Amniodarone Pulmonary fibrosis Bleomycin Busulfan Nitrofurantoin Rarely associated with chronic pulmonary fibrosis Cyclophosphamide Interstitial pneumonitis, which can lead to pulmonary fibrosis Methotrexate Sotalol (Option B) is a class III antiarrhythmic that primarily blocks potassium channels. It does not have significant pulmonary toxicity. Quinidine (Option C) is a class I antiarrhythmic , and it is not associated with pulmonary toxicity and is therefore not contraindicated in ILD. Lignocaine (Option D) is a class Ib antiarrhythmic which is mainly used for ventricular arrhythmias and is not associated with pulmonary toxicity. Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition, Page 561-563",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 21,
      "question": "A person presents with acute chest pain. Nitro-glycerine was given sublingually, and pain relief occurred within a minute. What is the mechanism of this drug?",
      "options": {
        "A": "Release of endothelin",
        "B": "Release of nitric oxide",
        "C": "Calcium channel blockade",
        "D": "Beta blockade"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer B - Release of nitric oxide Explanation: Relief from chest pain by use of sublingual Nitro-glycerine occurs due to the release of nitric oxide, which causes vasodilation of coronary arteries, thus causing increased blood flow to the ischemic region of the myocardium. Nitrates Drugs Glyceryl trinitrate Isosorbide dinitrate Isosorbide mononitrate Pentaerythritol tetranitrate MOA Venodilation → Reduce preload → Reduce myocardial contractility → Decreased O 2 demand. Dilates coronary artery (increase cGMP): effective in vasospastic angina. Redistribution of coronary blood flow to the ischemic area ( Robinhood phenomenon ). Uses Angina (stable, vasospastic and chronic) Acute coronary syndrome or myocardial infarction (STEMI/NSTEMI) Acute pulmonary edema Abdominal colicky pain Release of endothelin (Option A) by endothelial cells leads to potent vasoconstrictor. It increases vascular tone and blood pressure. It is not used for the treatment of angina. Calcium channel blockade (Option C) by Calcium channel blockers (e.g., amlodipine, verapamil) inhibits L-type calcium channels in vascular smooth muscle and cardiac myocytes, leading to vasodilation, decreased heart rate, and reduced contractility. It is not used for the treatment of angina. Beta blockade (Option D) by Beta-blockers (e.g., atenolol, metoprolol) antagonise beta-adrenergic receptors, reducing heart rate, myocardial contractility, and oxygen demand. Nitroglycerine does not interact with beta-adrenergic receptors. Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition, Page 609-613",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpharmacology/Cvs_Pharmacology-Previous_Year_Questions_Q21_exp.png",
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 22,
      "question": "A patient has pain in the facial nerve distribution while chewing and speaking. Which of the following drugs should be given for the treatment?",
      "options": {
        "A": "Lamotrigine",
        "B": "Carbamazepine",
        "C": "Phenobarbitone",
        "D": "Haloperidol"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer B - Carbamazepine Explanation: The patient's symptoms are indicative of trigeminal neuralgia, and Carbamazepine is the drug of choice for managing this condition due to its proven efficacy in reducing pain. Drugs for trigeminal neuralgia Drug Mechanism of Action Uses Side Effects Carbamazepine Inhibits high-frequency neuronal discharges and modulates voltage-gated sodium channels. Trigeminal neuralgia GTCS, partial seizures, bipolar disorder. Sedation, dizziness, ataxia, GI disturbances, bone marrow suppression, hypersensitivity reactions, water retention. Gabapentin Enhances GABA release modulates voltage-sensitive Ca2+ channels. Partial seizures, post-herpetic neuralgia, migraine prophylaxis. Sedation, tiredness, dizziness, tremor, unsteadiness. Diazepam Enhances GABAergic neurotransmission. Status epilepticus, Febrile seizure. Thrombophlebitis, hypotension, respiratory depression. Topiramate Multiple mechanisms, including sodium channel inactivation, GABA potentiation, glutamate receptor antagonism, and potassium channel modulation. GTCS, myoclonic epilepsy, and absence of seizures. Impairment of attention, sedation, ataxia, word-finding difficulties, poor memory, weight loss, paresthesias, renal stones. Lamotrigine (Option A) is an anticonvulsant medication used in the treatment of epilepsy and bipolar disorder. While it has some efficacy in neuropathic pain, it is not used for the treatment of trigeminal neuralgia. Phenobarbital (Option C) is a barbiturate that is primarily used as an anticonvulsant. It is not commonly used for the treatment of trigeminal neuralgia. Haloperidol (Option D) is an antipsychotic used primarily to treat psychotic disorders like schizophrenia. It has no role in the treatment of trigeminal neuralgia. Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition Page 400-403",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 23,
      "question": "Which of the subsequent antihypertensive medications are contraindicated during pregnancy?",
      "options": {
        "A": "Alpha methyldopa",
        "B": "Hydralazine",
        "C": "Propranolol",
        "D": "Labetalol"
      },
      "correct_answer": "C",
      "explanation": "adverse effects on fetal growth and development. Propranolol is generally avoided during pregnancy, particularly during the first trimester, due to concerns about its potential adverse effects on fetal growth and development. Incorrect Options: Option A: Alpha methyldopa- Alpha methyldopa is commonly used as an antihypertensive medication during pregnancy. It has a long history of safe use and is considered one of the first-line choices for managing hypertension in pregnant women. Option B: Hydralazine- Hydralazine is also frequently used in pregnancy to control blood pressure. It is considered safe for use during pregnancy and is often used as an alternative if other agents are not suitable or effective. Option D: Labetalol- Labetalol is commonly used in pregnancy to manage hypertension. It is considered safe and effective for use during pregnancy and is often recommended as a first-line choice for treating hypertension in pregnant wome n. Reference: .",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 24,
      "question": "Which of these drugs stimulates PPAR-alpha?",
      "options": {
        "A": "Gemfibrozil",
        "B": "Ezetimibe",
        "C": "Colestipol",
        "D": "Simvastatin"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer A - Gemfibrozil Gemfibrozil is a fibrate (fibric acid derivative) that acts as a PPAR - alpha agonist (Peroxisome proliferator-activated receptor alpha agonist). Class Fibrate or PPAR- α agonist Mechanism of action Activate peroxisome proliferator-activated receptor alpha (PPAR- α ), leading to the following effects: Reduce triglyceride production Elevate high-density lipoprotein (HDL) cholesterol levels Decrease hepatic triglyceride synthesis Uses Hyperlipidemia Adverse effects GI side effects (nausea, abdominal pain, diarrhea) Myopathy, especially when used with statins Hepatotoxicity (elevated liver enzymes) Renal dysfunction Gallbladder disease Contraindicated in children and pregnancy Ezetimibe (Option B) is a cholesterol absorption inhibitor that blocks dietary cholesterol absorption in the small intestine via PCIL1 transporter protein interference. It is used with statins for primary hypercholesterolemia. Colestipol (Option C) is a bile acid sequestrant that binds to bile acids in the intestine, preventing their reabsorption and promoting their excretion in the feces. They are used in adjunct with statin therapy. Simvastatin (Option D) is an HMG-CoA reductase inhibitor (statin) that works by inhibiting the production of cholesterol in the liver. Reference: Goodman and Gilman’s Pharmaceutical Basis of Therapeutics, 14th Edition, Page 687.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 25,
      "question": "A patient who has recently had a myocardial infarction (MI) presents for a follow-up. His cholesterol levels are as follows: total cholesterol 238 mg/dL, triglycerides 125 mg/dL, and HDL 50 mg/dL. He is currently taking atorvastatin, metoprolol, and aspirin. Which of the following medications should be added to his regimen? Ezetimibe Bempedoic acid Evolocumab Gemfibrozil",
      "options": {
        "A": "1,2",
        "B": "2,3",
        "C": "1,2,3",
        "D": "1,2,4"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) 1,2,3 Explanation: Gemfibrozil is mainly used to treat high triglycerides (Severe Hypertriglyceridemia) and low HDL cholesterol, but it is not the first-line agent for LDL cholesterol reduction in post-MI patients & also the patient has normal triglyceride levels. Ezetimibe (1) : Inhibits cholesterol absorption in the small intestine, reducing total cholesterol and LDL levels. Bempedoic acid (2) : Inhibits ATP-citrate lyase , which reduces cholesterol synthesis in the liver, leading to lower LDL levels. Evolocumab (3) : A PCSK9 inhibitor that binds to PCSK9, preventing it from degrading LDL receptors, thereby increasing the liver’s ability to clear LDL cholesterol from the bloodstream. Reference: Goodman and Gilman's Pharmacological Basis of Therapeutics, 14th Edition, Pages 743,744",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 26,
      "question": "Scientists administered norepinephrine to guinea pigs, resulting in an increase in systolic and diastolic blood pressure and a decrease in heart rate. What mechanism explains this response?",
      "options": {
        "A": "Beta-1 receptor blockade",
        "B": "Alpha-1 receptor blockade",
        "C": "Baroreceptor stimulation",
        "D": "Baroreceptor inhibition"
      },
      "correct_answer": "C",
      "explanation": "causes: ↑ Systolic and diastolic blood pressure (due to α I -mediated vasoconstriction). ↓ Heart rate (bradycardia) despite norepinephrine’s β I -stimulatory effects . This paradoxical bradycardia occurs due to the activation of the baroreceptor reflex in response to increased blood pressure. Baroreceptor Reflex: Aspect Details Mechanism Baroreceptors in carotid sinus and aortic arch detect BP changes Increased BP stretches receptors, sending signals to medulla via glossopharyngeal and vagus nerves Medulla inhibits vasoconstrictor center and stimulates vagal parasympathetic center Actions Vasodilation of blood vessels Decreased heart rate and contraction strength Reduced BP due to lower peripheral resistance and cardiac output Importance Maintains BP stability during activities like standing Fastest acting Tends to reset within 1-2 days for long-term regulation Beta-1 receptor blockade (Option A) is incorrect because norepinephrine stimulates β I receptors , increasing contractility, but the reflex bradycardia is due to vagal activation, not β I blockade. Alpha-1 receptor blockade (Option B) is incorrect because norepinephrine activates α I receptors , leading to vasoconstriction and increased blood pressure. Blocking α I receptors would cause vasodilation and hypotension , the opposite of the observed effect. Baroreceptor inhibition (Option D) is incorrect because if baroreceptors were inhibited, heart rate would increase (not decrease) due to unchecked sympathetic activation. Reference: Ganong’s Review of Medical Physiology, Edition 26, Pg 575, 576, 577,578, 579, 582, 583, 585, 586 Guyton and Hall Textbook of Medical Physiology, Edition 14, Pg 221, 222, 229, 236, 243, 244",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 27,
      "question": "A patient with rheumatoid arthritis is taking indomethacin and an ACE inhibitor for hypertension. What potential side effect is likely to be seen?",
      "options": {
        "A": "Hyperkalemia",
        "B": "Hypercalcemia",
        "C": "Hypernatremia",
        "D": "Hyperphosphatemia"
      },
      "correct_answer": "A",
      "explanation": "anti-inflammatory drug, NSAID) and an ACE inhibitor increases the risk of hyperkalemia due to their combined effects on renal function and potassium homeostasis . Mechanism: ACE inhibitors (e.g., enalapril, lisinopril) block angiotensin-converting enzymes , reducing aldosterone secretion . Aldosterone promotes potassium excretion , so reduced aldosterone leads to potassium retention . Indomethacin (NSAID) further reduces renal perfusion by inhibiting prostaglandins, worsening potassium retention. This can lead to hyperkalemia , particularly in patients with chronic kidney disease (CKD), dehydration, or concurrent diuretic use . Drug Interaction Mechanism Clinical Implication ACE Inhibitors + Potassium Supplements/K-sparing diuretics Risk of hyperkalemia due to reduced aldosterone secretion by ACE inhibitors combined with potassium-retaining agents. Monitoring serum potassium levels is crucial to avoid hyperkalemia, which can cause serious cardiac issues such as arrhythmias. ACE Inhibitors + NSAIDs NSAIDs can reduce the anti-hypertensive effects of ACE inhibitors and decrease renal blood flow, increasing the risk of acute renal failure (ARF) or oliguria. Use caution when combining NSAIDs with ACE inhibitors, and closely monitor renal function, particularly in high-risk patients. ACE Inhibitors + Lithium ACE inhibitors can increase the reabsorption of lithium, potentially leading to lithium toxicity. Monitor lithium levels carefully when starting or adjusting ACE inhibitors in patients taking lithium, and adjust the lithium dosage as needed. ACE Inhibitors + Antacids Reduced bioavailability of ACE inhibitors due to binding with antacids. Administer ACE inhibitors at least two hours before or after antacids to maintain their efficacy. ACE Inhibitors + Diuretics Diuretics enhance the hypotensive effects of ACE inhibitors by depleting sodium and raising renin levels. In patients already on diuretics, start ACE inhibitors at a low dose to minimise the risk of excessive blood pressure reduction initially. Hypercalcemia (Option B) is incorrect because neither NSAIDs nor ACE inhibitors cause significant calcium elevation. ACE inhibitors may slightly lower calcium levels by increasing urinary calcium excretion. Hypernatremia (Option C) is incorrect because ACE inhibitors do not cause sodium retention; instead, they promote mild natriuresis (sodium excretion). Hyperphosphatemia (Option D) is incorrect because NSAIDs and ACE inhibitors do not directly affect phosphate metabolism; hyperphosphatemia is more commonly seen in CKD due to decreased phosphate excretion. Reference: K D Tripathi, Essentials of Medical Pharmacology, 8th edition, Page 531",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 28,
      "question": "Which antihypertensive drug is contraindicated in pregnancy?",
      "options": {
        "A": "Methyldopa",
        "B": "Enalapril",
        "C": "Labetalol",
        "D": "Nifedipine"
      },
      "correct_answer": "B",
      "explanation": "pregnancy due to its teratogenic effects on fetal development . Risks in Pregnancy (Especially 2nd & 3rd Trimester): Fetal renal dysgenesis → Oligohydramnios → Pulmonary hypoplasia Hypocalvaria (skull hypoplasia) Fetal growth restriction Neonatal renal failure and anuria Why ACE Inhibitors Are Harmful in Pregnancy: ACE inhibitors block the renin-angiotensin-aldosterone system (RAAS) , which is essential for fetal kidney development . This results in reduced amniotic fluid (oligohydramnios) , leading to Potter sequence (lung hypoplasia, limb deformities). Adverse effects of ACEI: Adverse Effect Description Hypotension Decrease in blood pressure, especially upon initiation of therapy or with dosage increases. Hyperkalemia Increased serum potassium levels due to reduced aldosterone secretion. Cough Persistent dry cough, possibly due to bradykinin buildup in the lungs. Angioedema Due to increased bradykinin levels, swelling of deeper layers of skin, particularly around the eyes and lips, can be life-threatening. Rashes/Urticaria Skin reactions like rashes or hives occur in a small percentage of users. Dysgeusia Reversible taste changes are more common with captopril. Rare Effects Granulocytopenia (low white blood cells) and proteinuria (excess protein in urine) are more concerning in patients with kidney disease. Acute Renal Failure Possible in patients with bilateral renal artery stenosis due to decreased kidney filtration. Fetal Effects ACE inhibitors are contraindicated during pregnancy due to potential harm to the fetus, including fetal renal damage due to inhibition of the fetal renin-angiotensin system. Methyldopa (Option A) : Preferred for chronic hypertension (centrally acting α I -agonist). Labetalol (Option C) : Used in hypertensive emergencies and preeclampsia (combined α - & β -blocker). Nifedipine (Option D) : Safe for hypertension and preeclampsia (calcium channel blocker). Reference: K D Tripathi, Essentials of Medical Pharmacology, 8th edition, Page 531",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 29,
      "question": "Which of the following beta-adrenergic blockers used in the treatment of chronic heart failure (CHF) is known to prolong survival?",
      "options": {
        "A": "Bisoprolol",
        "B": "Labetalol",
        "C": "Propranolol",
        "D": "Atenolol"
      },
      "correct_answer": "A",
      "explanation": "blocker. It works by decreasing the heart rate, reducing myocardial contractility, and lowering blood pressure, which reduces the workload on the heart. Prolonging Survival: Bisoprolol is one of the beta-blockers that has been proven to improve survival in patients with chronic heart failure (CHF). It is specifically indicated in the management of CHF due to its ability to reduce mortality and hospitalization by counteracting the harmful effects of excessive sympathetic stimulation on the heart. Clinical Trials: The CIBIS-II trial (Cardiac Insufficiency Bisoprolol Study II) demonstrated a significant reduction in mortality and hospitalization rates in patients with heart failure treated with bisoprolol. Incorrect Options: Option B - Labetalol: Mechanism of Action: Labetalol is a non-selective beta-blocker with additional alpha-1 adrenergic blocking activity. Use in Heart Failure: Labetalol is primarily used for the management of hypertension and hypertensive emergencies rather than for chronic heart failure. It is not known to prolong survival in CHF and is not routinely used for this purpose. Option C - Propranolol: Mechanism of Action: Propranolol is a non-selective beta-blocker that affects both beta-1 and beta-2 receptors. Use in Heart Failure: Propranolol is generally used for conditions such as hypertension, angina, and arrhythmias but is not commonly used in the management of chronic heart failure. It does not have evidence supporting a survival benefit in CHF patients. Option D - Atenolol: Mechanism of Action: Atenolol is a selective beta-1 adrenergic blocker, similar to bisoprolol. Use in Heart Failure: Atenolol is less commonly used in chronic heart failure and has not shown a survival benefit in this population. It is more frequently used for managing hypertension and angina pectoris.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 30,
      "question": "Which anticoagulant is recommended for a pregnant female at 29 weeks of gestation who develops deep vein thrombosis (DVT) with calf tenderness and is diagnosed via Doppler ultrasound?",
      "options": {
        "A": "Warfarin",
        "B": "Low molecular weight heparin (LMWH)",
        "C": "Apixaban",
        "D": "Rivaroxaban"
      },
      "correct_answer": "B",
      "explanation": "preferred anticoagulant for treating DVT in pregnancy. It is safe, does not cross the placenta, and has a lower risk of causing heparin-induced thrombocytopenia (HIT) compared to unfractionated heparin. LMWH is also effective in preventing the extension of the thrombus and reducing the risk of pulmonary embolism, making it the standard treatment for DVT during pregnancy. Incorrect Options: Option A - Warfarin: Warfarin is contraindicated in pregnancy, especially during the first trimester and near term, due to its teratogenic effects and the risk of causing fetal bleeding. Warfarin crosses the placenta and can lead to fetal warfarin syndrome, characterized by congenital malformations. Therefore, it is not recommended for use in pregnant women. Option C - Apixaban: Apixaban is a direct oral anticoagulant (DOAC) that is not recommended for use during pregnancy because its safety in pregnant women has not been established. DOACs, including apixaban, are generally avoided during pregnancy due to concerns about potential fetal exposure and lack of sufficient data on their effects. Option D - Rivaroxaban: Like apixaban, rivaroxaban is a DOAC and is not recommended for use in pregnancy due to the lack of sufficient safety data. The potential for fetal exposure and unknown risks make DOACs less desirable compared to LMWH, which has a well-established safety profile in pregnancy.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 31,
      "question": "A hypertensive patient is suffering from frequent attacks of renal colic. Preferred anti hypertensive drug is:",
      "options": {
        "A": "Ethacrynic acid",
        "B": "Acetazolamide",
        "C": "Hydrochlorothiazide",
        "D": "Spironolactone"
      },
      "correct_answer": "C",
      "explanation": "to treat hypertension. It is particularly useful in patients with renal colic due to its ability to reduce calcium excretion in the urine, which can help prevent the formation of calcium-containing kidney stones. Thiazide diuretics are effective in managing hypertension and have a protective effect against stone formation by decreasing calcium levels in the urine. Incorrect Options: Option A - Ethacrynic Acid: Ethacrynic acid is a loop diuretic and is not typically used for hypertension in the long term. It is used in situations where more potent diuresis is required or where thiazide diuretics are ineffective. Loop diuretics can increase calcium excretion in the urine, which could exacerbate kidney stone formation rather than prevent it. Option B - Acetazolamide: Acetazolamide is a carbonic anhydrase inhibitor that works as a diuretic but is not commonly used for hypertension. It can lead to increased bicarbonate excretion and subsequent metabolic acidosis. It is more commonly used in conditions like glaucoma, altitude sickness, or metabolic alkalosis. Its effect on calcium excretion is not beneficial for preventing renal colic. Option D - Spironolactone: Spironolactone is a potassium-sparing diuretic that works by antagonizing aldosterone. It is used to treat conditions like heart failure, primary aldosteronism, and as part of combination therapy for hypertension. However, it does not affect calcium excretion and is not typically used for managing renal colic or calcium-based kidney stones.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 32,
      "question": "A hypertensive patient stopped antihypertensive medication due to dry eyes, dry mouth and constipation. After stopping the drug, he developed hypertensive emergency (BP > 180/120). Most likely drug is:",
      "options": {
        "A": "Clonidine",
        "B": "Lisinopril",
        "C": "Amlodipine",
        "D": "Telmisartan"
      },
      "correct_answer": "A",
      "explanation": "It works by decreasing sympathetic outflow, which lowers blood pressure. When clonidine is stopped abruptly, it can lead to a rebound increase in blood pressure, potentially causing a hypertensive emergency. Symptoms like dry eyes, dry mouth, and constipation are common side effects of clonidine. Therefore, the development of a hypertensive emergency after stopping clonidine is consistent with its withdrawal effects. Incorrect Options: Option B - Lisinopril: Lisinopril is an ACE inhibitor used to treat hypertension and heart failure. It typically does not cause rebound hypertension if discontinued. Common side effects include cough and elevated potassium levels, but not dry eyes, dry mouth, or constipation. Discontinuation of lisinopril is unlikely to cause a hypertensive emergency. Option C - Amlodipine: Amlodipine is a calcium channel blocker used to manage hypertension and angina. It generally does not cause rebound hypertension when stopped. Side effects can include swelling, dizziness, and flushing, but not dry eyes, dry mouth, or constipation. Discontinuation of amlodipine is less likely to result in a hypertensive emergency. Option D - Telmisartan: Telmisartan is an angiotensin II receptor blocker (ARB). Similar to lisinopril, discontinuation of telmisartan typically does not cause rebound hypertension. Common side effects include dizziness and hyperkalemia, but not dry eyes, dry mouth, or constipation. A hypertensive emergency due to the abrupt discontinuation of telmisartan is unlikely.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 33,
      "question": "A patient with raised triglyceride started on medication. He soon developed flushing, gout and raised liver enzymes. Likely cause is:",
      "options": {
        "A": "Nicotinamide",
        "B": "Atorvastatin",
        "C": "Fenofibrate",
        "D": "Cholestyramine"
      },
      "correct_answer": "A",
      "explanation": "nicotinamide) is commonly used to lower triglycerides and raise HDL cholesterol. However, it is known to cause several side effects, including flushing , hyperuricemia (which can precipitate gout ), and elevated liver enzymes (indicating hepatotoxicity). Flushing is a particularly well-known side effect due to the vasodilatory effect of niacin, which can be mitigated by taking aspirin before the dose. Incorrect Options: Option B - Atorvastatin: Atorvastatin, a statin, is used to lower LDL cholesterol and triglycerides. While it can cause elevated liver enzymes and muscle-related side effects (myopathy), it is not typically associated with flushing or gout. Option C - Fenofibrate: Fenofibrate is a fibrate that is effective in lowering triglycerides. It can occasionally cause elevated liver enzymes and muscle-related side effects, but it is not typically associated with flushing or gout. Option D - Cholestyramine: Cholestyramine is a bile acid sequestrant used to lower LDL cholesterol. It can cause gastrointestinal side effects such as constipation but is not associated with flushing, gout, or elevated liver enzymes.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 34,
      "question": "An unconscious patient found to have hot dry skin, dilated pupils, abnormal slurred speech. Most likely overdose is?",
      "options": {
        "A": "Dhatura",
        "B": "Cannabis",
        "C": "Alcohol",
        "D": "Cocaine"
      },
      "correct_answer": "A",
      "explanation": "scopolamine, and hyoscyamine. An overdose of Dhatura can lead to anticholinergic syndrome, characterized by hot, dry skin (due to inhibition of sweating), dilated pupils (mydriasis), and altered mental status, which may include slurred speech, confusion, and hallucinations. The combination of these symptoms is classic for anticholinergic toxicity. Incorrect Options: Option B - Cannabis: Cannabis intoxication can lead to symptoms such as altered mental status, red eyes, increased appetite, and dry mouth. However, it is not typically associated with hot, dry skin or significant pupil dilation. The symptoms described are more consistent with anticholinergic toxicity rather than cannabis intoxication. Option C - Alcohol: Alcohol intoxication often presents with symptoms such as slurred speech, incoordination, and altered mental status. However, alcohol does not typically cause hot, dry skin or dilated pupils. In fact, alcohol may lead to hypothermia and constricted pupils in severe cases. Option D - Cocaine: Cocaine, a stimulant, typically causes symptoms such as dilated pupils, tachycardia, sweating, and agitation. However, it usually does not cause hot, dry skin, which is more characteristic of anticholinergic toxicity. The slurred speech and hot, dry skin are not typical of cocaine intoxication.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 35,
      "question": "Which of the following adverse effects is least likely to be associated with the use of amiodarone?",
      "options": {
        "A": "Hypothyroidism",
        "B": "Hyperthyroidism",
        "C": "Gynecomastia",
        "D": "Pulmonary fibrosis"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Gynecomastia Explanation: Amiodarone is a potent antiarrhythmic drug used primarily for ventricular arrhythmias and atrial fibrillation . While it has several potential side effects and a long half-life, gynecomastia is not one of the common adverse effects. Amiodarone MOA It prolongs action potential duration and QT interval by blocking delayed rectifier K+ channels. Blocks inactivated Na+ channels, with rapid channel recovery (Decrease phase 0 slope). It partially inhibits myocardial Ca2+ channels, adding to its antiarrhythmic effects. It is used to treat both atrial and ventricular fibrillation. Drug interactions Inhibits CYP3A4, CYP2C9, and P-glycoprotein, leading to potential interactions with drugs metabolized by this system. Increases plasma levels of digoxin and warfarin. Additive AV block with beta-blockers or calcium channel blockers. Adverse reactions Hypotension and Bradycardia (with i.v administration or after drug accumulation) Photosensitivity : Skin pigmentation - Purple colour (purple man syndrome, smurf syndrome) Corneal microdeposits: Reversible upon drug discontinuation. Pulmonary alveolitis and fibrosis, on long-term use (Option D ruled out) Peripheral neuropathy Thyroid Dysfunction : Interfere with thyroid function as it acts as a source of iodine and can potentially lead to goitre, hypothyroidism (Wolf Chaikoff effect) , or, in rare cases, hyperthyroidism (Jos-Basedow effect). (Option A and B ruled out) Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition, Pages 577, 578",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 36,
      "question": "Identify the Pcsk9 inhibitor.",
      "options": {
        "A": "Evolocumab",
        "B": "Lomitapide",
        "C": "Mipomersen",
        "D": "Torcetrapib"
      },
      "correct_answer": "A",
      "explanation": "hypercholesterolemia. It is a monoclonal antibody that inhibits Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9). By binding to PCSK9, it prevents PCSK9 from degrading the low-density lipoprotein (LDL) receptors on hepatocytes. This increases the number of LDL receptors available to clear LDL cholesterol from the blood, thus lowering LDL cholesterol levels. Incorrect Options: Option B - Lomitapide: Lomitapide inhibits the microsomal triglyceride transfer protein (MTP), which is essential for the assembly and secretion of very low-density lipoprotein (VLDL) in the liver. This reduces the levels of LDL cholesterol and triglycerides. Option C - Mipomersen: Mipomersen is an antisense oligonucleotide that targets and inhibits the synthesis of apolipoprotein B-100 (apoB-100), the primary protein component of LDL and VLDL. This reduces LDL cholesterol. Option D - Torcetrapib: Torcetrapib was a cholesteryl ester transfer protein (CETP) inhibitor intended to increase high-density lipoprotein (HDL) cholesterol. However, its development was terminated due to adverse effects in clinical trials, including increased mortality.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 37,
      "question": "Which of the following drugs reduces mortality in patients with heart failure with reduced ejection fraction (HFREF)?",
      "options": {
        "A": "Metoprolol",
        "B": "Furosemide",
        "C": "Torsemide",
        "D": "Prazosin"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer A - Metoprolol Multiple large-scale clinical trials have shown that Metoprolol (a second-generation/ cardioselective I -blocker) reduces mortality in patients with heart failure with reduced ejection fraction (HFREF). It is more potent in blocking I 1-receptor (cardiac muscle) than I 2-receptor (bronchial muscles). It is used as secondary prophylaxis for myocardial infarction (to prevent reinfarction and arrhythmias) and to treat hypertension, angina, and heart failure. Side effects of beta-blockers: Cardiac side effects Extracardiac side effects Withdrawal can lead to the precipitation of an acute MI. Negative chronotropic effects include the development of sinus bradycardia and heart block. Heart failure may exacerbate symptoms in patients with decompensated heart failure or preexisting myocardial dysfunction. Increased airway resistance (contraindicated in patients with asthma due to bronchospasm). Exacerbation of peripheral artery disease and worsen claudication and precipitate Raynaud's disease. Masking of the hypoglycemic signs (tachycardia). Hyperkalemia Depression, fatigue, and sexual dysfunction such as erectile dysfunction. Weight gain Furosemide (Option B) and Torsemide (Option C) are loop diuretics commonly used in heart failure to reduce fluid buildup and relieve symptoms. While they provide symptomatic benefits, they do not improve mortality. These drugs are widely used in acute decompensated heart failure. Prazosin (Option D) is an alpha-blocker that is used primarily to treat high blood pressure and benign prostatic hyperplasia, but it is not recommended for the management of heart failure and has not been shown to reduce mortality in HFREF patients. Reference: Goodman and Gilman’s Pharmaceutical Basis of Therapeutics, 14th Edition, Page 275. KD Tripathi Essentials of pharmacology, 8th Edition, Page 158, 164.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 38,
      "question": "Which of the following statements is correct regarding the mechanism of action of labetalol?",
      "options": {
        "A": "Directly acts as arterial vasodilator resulting in indirect effect tachycardia",
        "B": "Blocks both alpha and beta-adrenergic receptors",
        "C": "Primarily acts as a vasodilator with little effect on arterioles",
        "D": "Decreases peripheral vascular resistance by directly acting as a relaxant for vascular smooth muscles"
      },
      "correct_answer": "D",
      "explanation": "vascular smooth muscles Correct Answer B - Blocks both alpha and beta-adrenergic receptors Labetalol is a non-selective beta-blocker and an alpha-blocker that blocks both beta- and alpha-adrenergic receptors. It reduces sympathetic nervous system activity, leading to decreased heart rate, decreased contractility, and vasodilation. It reduces the effects of epinephrine and norepinephrine on the heart, decreasing heart rate and contractility (beta-blocker). It reduces arterial resistance by causing dilation of the blood vessels, leading to decrease in blood pressure (alpha-1 blocker). It is the drug of choice for hypertension in pregnancy. Non selective I 1 + I 2 blocker Cardioselective I 1 blocker Without ISA With ISA With I blocking activity Metoprolol Esmolol Atenolol Bisoprolol Acebutolol Betaxolol Nebivolol Propranolol Sotalol Timolol Pindolol Celiprolol Oxprenolol Penbutolol Pindolol Bopindolol Labetalol Carvedilol ISA: intrinsic sympathomimetic action Directly acts as an arterial vasodilator, resulting in indirect effect tachycardia (Option A): Labetalol primarily acts as a non-selective beta-blocker and alpha-blocker. Its vasodilatory effect is mainly due to its blockade of alpha-adrenergic receptors, leading to the relaxation of vascular smooth muscle resulting in decreased systemic vascular resistance and blood pressure. Primarily acts as a vasodilator with little effect on arterioles (Option C): Labetalol acts as both a beta-blocker and an alpha-blocker, causing vasodilation in both arteries and arterioles. Its alpha-blocking activity leads to arteriolar dilation, while its beta-blocking activity contributes to arterial vasodilation. Decreases peripheral vascular resistance by directly acting as a relaxant for vascular smooth muscles (Option D): Labetalol decreases peripheral vascular resistance, but it does so indirectly by blocking both alpha-adrenergic receptors and beta-adrenergic receptors, resulting in reduced vasoconstrictor effects of catecholamines such as norepinephrine and epinephrine. This results in vasodilation and decreased peripheral vascular resistance. It does not directly act as a relaxant for vascular smooth muscles. Reference: KD Tripathi Essentials of pharmacology, 8th Edition, Page 162,163,165.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 39,
      "question": "Drug of choice for acute rheumatic fever?",
      "options": {
        "A": "Digoxin",
        "B": "Aspirin",
        "C": "Amiodarone",
        "D": "Furosemide"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Aspirin Explanation: Aspirin is used in acute rheumatic fever (ARF) for its anti-inflammatory and antipyretic properties to control symptoms of arthritis and fever . ARF is a complication of Group A Streptococcus (GAS) throat infection, often following untreated or inadequately treated strep throat. The main goals in the treatment of ARF are to reduce inflammation , prevent further damage to the heart , and manage symptoms such as joint pain and fever. Management of ARF Treatment for Medication used Group streptococcal infection Penicillin/Erythromycin/Azithromycin. 10 days or oral Amoxicillin or a single dose of IM benzathine penicillin. Azithromycin in case of Penicillin allergy. Symptomatic management Salicylates like aspirin (NSAIDs as an alternative option) It is the first-line treatment for arthritis , fever , and inflammation . Dose: High initially, then taper as symptoms improve. Carditis Corticosteroids. Diuretics like Furosemide are used if heart failure symptoms due to rheumatic carditis are present. (Option D ruled out) Chorea It is managed conservatively, or Valproic acid is used for the sedation CCF Diuretics and vasodilators are used. Prophylaxis (is essential to prevent recurrent infections and further damage to the heart) Inj. Benzathine penicillin is given every 3-4 weeks IM 6 lakh IU in children ≤ 27 kg. 1.2 million IU in children >27 kg Bed rest is advised Digoxin (Option A) is a cardiac glycoside used to treat conditions like heart failure and atrial fibrillation . It is not used to treat acute rheumatic fever, unless there is heart failure due to rheumatic carditis . Even then, it would only be used as a supportive therapy , not as the primary treatment for ARF. Amiodarone (Option C) is an antiarrhythmic drug mainly used for arrhythmias like ventricular tachycardia or atrial fibrillation . It may be used in patients with arrhythmias that can occur as a consequence of RHD, but it is not the drug of choice for treating acute rheumatic fever itself. Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition, Page 839",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 40,
      "question": "The true statement among the following is ___:",
      "options": {
        "A": "Telmisartan dose should be reduced in renal failure but not in hepatic failure.",
        "B": "Irbesartan dose should be reduced in case of mild-moderate hepatic failure and renal failure.",
        "C": "Candesartan dose should be reduced in mild-moderate liver failure but not in renal failure.",
        "D": "Losartan acts as a thromboxane A2 antagonist and inhibits platelet aggregation."
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Losartan acts as a thromboxane A2 antagonist and inhibits platelet aggregation. Losartan is an angiotensin II receptor antagonist that blocks the binding of angiotensin II to the AT1 receptor subtype, leading to the dilation of blood vessels and reduced blood pressure. It also blocks thromboxane A2 receptors and has some platelet antiaggregatory properties. Telmisartan dose should be reduced in renal failure but not in hepatic failure (Option A): Telmisartan is primarily eliminated by the liver and metabolized by the cytochrome P450 system. In case of hepatic impairment, the dose of telmisartan should be reduced. The dose does not need to be reduced in renal failure. Irbesartan dose should be reduced in case of mild-moderate hepatic failure and renal failure (Option B): Irbesartan is metabolized by the liver and excreted by the kidneys. In case of mild to moderate hepatic impairment or renal impairment, the dose should be reduced. Candesartan dose should be reduced in mild-moderate liver failure but not in renal failure (Option C): Candesartan is mainly eliminated through the liver and excreted through the bile. In case of mild to moderate liver failure, the dose of candesartan should be reduced, but no dose adjustment is required in renal failure. Reference: K D Tripathi, Essentials of Medical Pharmacology, 8th Edition, Page 536",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 41,
      "question": "A patient with a previous MI and ventricular arrhythmia is on treatment for a few months. He developed fatigue, dyspnea and weight gain. He had also developed pulmonary fibrosis. Which of the following drugs is responsible for this?",
      "options": {
        "A": "Amiodarone",
        "B": "Atenolol",
        "C": "Aspirin",
        "D": "Spironolactone"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer A - Amiodarone Amiodarone , a potassium channel blocker and class 3 anti-arrhythmic drug, is used to treat both atrial and ventricular fibrillation. It may cause side effects such as fatigue, dyspnea, weight gain, and, with prolonged use, pulmonary fibrosis. Mechanism of Action Prolonged action potential duration and QT interval by blocking delayed rectifier K+ channels. Blocks inactivated Na + channels, with rapid channel recovery (Decrease phase 0 slope). Partially inhibits myocardial Ca 2+ channels, adding to its antiarrhythmic effects. Adverse effects Hypotension and Bradycardia (with i.v administration or after drug accumulation) Photosensitivity : Skin pigmentation - Purple color (Purple man syndrome, smurf syndrome) Corneal microdeposits: Reversible upon drug discontinuation. Pulmonary alveolitis and fibrosis (On long-term use) Peripheral neuropathy Thyroid Dysfunction: Interfere with thyroid function as it acts as a source of iodine and can potentially lead to goitre, hypothyroidism (Wolf Chaikoff effect) , or, in rare cases, hyperthyroidism (Jos-Basedow effect). Drug Interactions Inhibits CYP3A4, CYP2C9, and P-glycoprotein, leading to potential interactions with drugs metabolized by this system. Increases plasma levels of digoxin and warfarin. Additive AV block with beta-blockers or calcium channel blockers. Atenolol (Option B) is a beta-blocker used for managing hypertension, stable heart failure, post-myocardial infarction (to prevent sudden cardiac death), and the prevention of left ventricular hypertrophy. Side effects include fatigue, reduced libido, cognitive issues, nightmares, bradycardia, hypotension, rebound hypertension, aggravated ischemia, angina, MI, and increased triglycerides/LDL. Aspirin (Option C) is an antiplatelet medication that irreversibly inhibits COX-1, thereby preventing platelet aggregation. It is the drug of choice for myocardial infarction (MI), stroke, and Buerger's disease. Spironolactone (Option D) is a potassium-sparing diuretic that either inhibits sodium channels in the distal nephron or blocks aldosterone receptors. It is used to treat heart failure and hyperaldosteronism. Side effects include hyperkalemia and gynecomastia. Reference: Goodman and Gilman’s Pharmacological Basis of Therapeutics 14th Edition, Page 577-578.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 42,
      "question": "Below is an image of angiotensin II synthesis and neprilysin action with two arrows at ACE and Neprilysin. Which drug acts on both enzymes?",
      "options": {
        "A": "Sacubitril",
        "B": "Omapatrilat",
        "C": "Losartan",
        "D": "Nesiritide"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer B - Omapatrilat Omapatrilat is a dual inhibitor of Neprilysin and Angiotensin-Converting Enzyme (ACE), as mentioned above. This dual inhibition leads to increased levels of bradykinin, a peptide that can cause vasodilation and increased vascular permeability. The accumulation of bradykinin is associated with a higher risk of severe angioedema, which is a serious and potentially life-threatening side effect. Omapatrilat Mechanism Uses Primarily for the treatment of hypertension and heart failure . Adverse Effects Angioedema Hypotension Cough Dizziness Fatigue Sacubitril (Option A) is ARNI (Angiotensin Receptor-Neprilysin Inhibitor) used in heart failure with reduced ejection fraction (HFrEF), having side effects such as hypotension, hyperkalemia, renal impairment, and angioedema. Losartan (Option C) is an Angiotensin Receptor Blocker (ARB) that functions as a competitive antagonist and inverse agonist at AT1 receptors. Additionally, it has an antiplatelet effect by blocking thromboxane A2 receptors and demonstrates uricosuric properties, which could be advantageous for managing gout. Nesiritide (Option D) is a recombinant human BNP (B-type Natriuretic Peptide), that acts by increasing the levels of cyclic GMP, promoting vasodilation and natriuresis. It does not act on RAAS or NEP pathways.",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpharmacology/Cvs_Pharmacology-Previous_Year_Questions_Q42_q.png",
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 43,
      "question": "A patient presented to the outpatient department with fatigue, and exertional and nocturnal dyspnoea. On examination, bilateral pedal oedema is noted. Auscultation reveals an S3 gallop and rales in both the lungs. Which of the following drugs can be used to prevent the progression of the disease?",
      "options": {
        "A": "Verapamil",
        "B": "Digoxin",
        "C": "Captopril",
        "D": "Carvedilol"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C - Captopril The presence of fatigue, exertional dyspnea, pedal edema, and an S3 gallop points towards heart failure. In this case, captopril (an ACE inhibitor) can be used to help prevent disease progression. Drugs to prevent the progression of heart failure: Inotropic drugs like digoxin Diuretics ACE inhibitors Angiotensin receptor blockers Beta-blockers Vasodilators like hydralazine, nitroprusside Synthetic BNP: nesiritide Neprilysin inhibitor: Sacubitril Aldosterone antagonists SGLT-2 inhibitors like dapagliflozin The first drugs patient is started on as soon as a diagnosis of Heart failure is made are: ACE inhibitors, ARBs, or ARNI (Angiotensin Receptor/Neprilysin Inhibitor). There are many contraindications to beta-blockers, so the patient is usually started on a very low dose. Verapamil (Option A) is a Calcium channel blocker, that is absolutely contraindicated in CHF. Digoxin (Option B) is incorrect as it has no role in decreasing mortality in heart failure. It only increases the force of contraction. Carvedilol (Option D) is incorrect as there are many contraindications to beta blockers, and they are not considered first line. Reference: Goodman & Gillman’s pharmacological basis of therapeutics, 14th Edition, Page 652.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 44,
      "question": "A 32-year-old pregnant female presents to the emergency department with a BP of 220/120mm Hg, along with headache, seizure, and blurred vision. Which of the following is the preferred intravenous medication for the management of hypertension in pregnancy?",
      "options": {
        "A": "IV Labetalol",
        "B": "IV nitroglycerine",
        "C": "IV hydralazine",
        "D": "IV sodium nitroprusside"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) IV Labetalol Explanation: The patient’s presentation is suggestive of a hypertensive crisis. IV Labetalol is the preferred intravenous medication for the management of hypertension in pregnancy due to its efficacy and safety profile. It is a non-selective beta-blocker, which has both alpha and beta-blocking effects, leading to vasodilation and a subsequent reduction in blood pressure. Initial IV dose: 10–20 mg, then 20–80 mg every 10–30 mins up to 300 mg. Continuous IV infusion: 1–2 mg/min. Fewer side effects than alternatives and less tachycardia. Incorrect Options: IV nitroglycerine (Option B) is a vasodilator that can reduce blood pressure by causing venodilation, which decreases preload . It is not typically the first choice for pregnant women. IV hydralazine (Option C) is a vasodilator that is reserved for cases with cardiac/renal dysfunction in pregnancy. It is used as a second-line drug to control hypertension in pregnancy. IV sodium nitroprusside (Option D) is a potent vasodilator used in hypertensive crisis, but it is not a first-line drug preferred in pregnancy. Reference: K D Tripathi, Essentials of Medical Pharmacology, 8th Edition, Pages 615 - 617 William’s Obstetrics, 26th Edition, Pages 950-951",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 45,
      "question": "A 55-year-old male patient with a history of hyperlipidemia was started on statins for elevated triglyceride levels. Despite the statin therapy, his triglycerides remain persistently elevated at over 600 mg/dL. Which of the following medications should be administered next to help manage the triglyceride levels?",
      "options": {
        "A": "Fibrates",
        "B": "Niacin",
        "C": "Statins",
        "D": "Resins"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Fibrates Explanation: Fibrates (e.g., gemfibrozil and fenofibrate) are the most effective drugs for lowering triglycerides. MOA: Activates PPAR- α § I expression of genes involved responsible for triglycerides breakdown and VLDL clearance. Fibrates can I triglycerides and I HDL cholesterol levels. Incorrect Options: Niacin (Option B) is Vitamin B3 or nicotinic acid. It inhibits lipolysis in adipose tissue and can lower triglycerides and increase HDL cholesterol, but it is less effective than fibrates for triglyceride lowering. Statins (Option C) are primarily used to lower LDL cholesterol, but they have a modest effect on triglycerides. Since this patient’s triglycerides are still elevated despite statin therapy, adding a fibrate would be more appropriate. Resins (Option D) are drugs that include cholestyramine, colestipol, and colesevelam. They are used in adjunct with statin therapy, and they are safe to use in pregnancy. Reference: Goodman and Gilman Pharmacological Basis of Therapeutics, 14th Edition, Pages 734, 738, 739",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 46,
      "question": "Which of the following is the best drug to reduce LDL cholesterol levels?",
      "options": {
        "A": "Niacin",
        "B": "Fibrates",
        "C": "Statins",
        "D": "Resins"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Statins Explanation: Statins (e.g., atorvastatin and rosuvastatin) are the most effective class of drugs for lowering LDL cholesterol. They work by inhibiting HMG-CoA reductase, the enzyme responsible for cholesterol synthesis in the liver, leading to decreased cholesterol production and increased LDL receptor activity, thereby reducing LDL levels in the blood. Most potent statin: Rosuvastatin Most efficacious statin : Rosuvastatin > Atorvastatin Longest-acting statin: Rosuvastatin > Atorvastatin Safe in renal failure: Atorvastatin Incorrect Options: Niacin (Option A) is Vitamin B3 or nicotinic acid. It inhibits lipolysis in adipose tissue and I triglyceride production by the liver. It also I HDL levels. Fibrates (Option B) activate peroxisome proliferator-activated receptor alpha (PPAR- α ) and reduce triglyceride production, elevate HDL cholesterol levels and decrease hepatic triglyceride synthesis. Resins (Option D) are drugs that include cholestyramine, colestipol, and colesevelam. They are used in adjunct with statin therapy, and they are safe to use in pregnancy. Reference: Goodman and Gilman’s Pharmacological Basis of Therapeutics, 14th Edition, Pages 735 - 736",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 47,
      "question": "Which of the following GPCRs does not act via the K + channel ?",
      "options": {
        "A": "Angiotensin 1 receptor",
        "B": "Muscarinic M2 receptor",
        "C": "Dopamine D2 receptor",
        "D": "Serotonin 5 HT 1 receptor"
      },
      "correct_answer": "A",
      "explanation": "receptor (GPCR) that does not directly act via a K + channel. Activation of the angiotensin 1 receptor by angiotensin II leads to intracellular signaling through G proteins and subsequent activation of downstream pathways, such as the phospholipase C (PLC) pathway and the mitogen-activated protein kinase (MAPK) pathway. These pathways result in various cellular responses, including vasoconstriction, aldosterone release, and increased blood pressure regulation. While these pathways can indirectly influence ion channels and cellular activity, they don't directly modulate K + channels. Incorrect Options: Option B - Muscarinic M2 receptor : The muscarinic M2 receptor is a GPCR that primarily acts via the activation of K + channels. When activated by acetylcholine, the M2 receptor initiates a signaling cascade that involves the beta-gamma subunits of G proteins binding to and activating K + channels, leading to hyperpolarization of the cell membrane and a decrease in heart rate. Option C - Dopamine D2 receptor : The dopamine D2 receptor is also a GPCR that primarily acts by inhibiting adenylyl cyclase activity, reducing cyclic AMP (cAMP) levels, and indirectly modulating ion channels and cellular responses. While the D2 receptor's activation can have effects on ion channels, it doesn't directly act on K + channels. Option D - Serotonin 5 HT 1 receptor : The serotonin 5-HT1 receptor is a GPCR that can have various effects, including modulation of ion channels and second messenger pathways. Similar to the other receptors mentioned, it doesn't directly act via K + channels. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 48,
      "question": "Propranolol is drug of choice for:",
      "options": {
        "A": "Ulcerated infantile hemangioma",
        "B": "Lymphangioma circumscriptum",
        "C": "Capillary malformation",
        "D": "Pyogenic granuloma"
      },
      "correct_answer": "A",
      "explanation": "infantile hemangioma. Propranolol is a non-selective beta-blocker that has been found to be highly effective in treating ulcerated infantile hemangiomas, which are benign tumors of blood vessels that commonly occur in infants. Propranolol helps to reduce the size and improve the appearance of the hemangioma by causing vasoconstriction and reducing blood flow to the affected area. It also promotes the regression of the abnormal blood vessels. Incorrect Options: Option B - Lymphangioma circumscriptum: Lymphangiomas are malformations of the lymphatic vessels, and propranolol is not the drug of choice for this condition. Propranolol has no effect on lymphatic system. Surgical excision or other treatment modalities may be employed. Option C - Capillary malformation: Propranolol is not the primary treatment for capillary malformations. Other treatment options, such as laser therapy, may be considered. Option D - Pyogenic granuloma: Pyogenic granuloma is a benign vascular lesion that typically occurs on the skin or mucous membranes. Propranolol is not commonly used as a first-line treatment for this condition, and other treatments, such as surgical excision or cauterization, may be more appropriate. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 49,
      "question": "Which medication is known to induce orthostatic (postural) hypotension and may lead to potentially severe blood pressure drops when patients transition from sitting or lying down to a standing position, potentially causing dizziness, lightheadedness, or even fainting?",
      "options": {
        "A": "Metformin",
        "B": "Prazosin",
        "C": "Acarbose",
        "D": "Nor-adrenaline"
      },
      "correct_answer": "B",
      "explanation": "hypertension. However, it can also cause postural hypotension, which is a drop in blood pressure upon standing up from a sitting or lying position. This can lead to dizziness, lightheadedness, and an increased risk of falls, particularly in elderly patients who may already have compromised balance and coordination. Prazosin works by blocking the alpha-1 adrenergic receptors, which results in vasodilation and relaxation of smooth muscles in blood vessels, leading to a decrease in blood pressure. However, this vasodilatory effect can cause a sudden drop in blood pressure when changing positions, especially from lying down to standing. Incorrect Options: Option A - Metformin: Metformin is an antidiabetic medication that does not typically cause postural hypotension. Its primary action is to decrease glucose production in the liver and increase insulin sensitivity, making it a commonly used medication for the management of type 2 diabetes. Option C - Acarbose: Acarbose is an alpha-glucosidase inhibitor used in the treatment of type 2 diabetes. It does not have a direct effect on blood pressure and is not associated with postural hypotension. Option D - Nor-adrenaline: Nor-adrenaline (norepinephrine) is a naturally occurring neurotransmitter and hormone that acts as a vasoconstrictor. It is not typically associated with postural hypotension. In fact, it can increase blood pressure by constricting blood vessels. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 50,
      "question": "Isosorbide dinitrate is indicated for congestive heart failure in combination with which of the following vasodilators ?",
      "options": {
        "A": "Minoxidil",
        "B": "Hydralazine",
        "C": "Nimodipine",
        "D": "Nitrendipine"
      },
      "correct_answer": "B",
      "explanation": "the treatment of congestive heart failure. Hydralazine is a direct-acting vasodilator that works by relaxing the smooth muscles of the blood vessels, thereby reducing peripheral resistance and improving cardiac output. Incorrect Options: Option A - Minoxidil: Minoxidil is a potent vasodilator primarily used for the treatment of hypertension and male pattern baldness. It is not commonly used in combination with isosorbide dinitrate for congestive heart failure. Option C - Nimodipine: These are calcium channel blockers primarily used for the treatment of cerebral vasospasm following subarachnoid hemorrhage. They are not typically used in combination with isosorbide dinitrate for congestive heart failure. Option D - Nitrendipine: These are calcium channel blockers primarily used for the treatment of cerebral vasospasm following subarachnoid hemorrhage. They are not typically used in combination with isosorbide dinitrate for congestive heart failure. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 51,
      "question": "What is the mechanism of action of sodium nitroprusside ?",
      "options": {
        "A": "Increased cAMP",
        "B": "Stimulation of gunaylyl cyclase",
        "C": "Calcium channel blockage",
        "D": "K + channel opener"
      },
      "correct_answer": "B",
      "explanation": "for the rapid reduction of blood pressure in hypertensive emergencies. Its mechanism of action involves the stimulation of guanylyl cyclase, leading to an increase in cyclic guanosine monophosphate (cGMP) levels within smooth muscle cells. This, in turn, leads to various intracellular effects that result in vasodilation and decreased systemic vascular resistance. Incorrect Options: Option A - Increased cAMP : This option is not the mechanism of action of sodium nitroprusside. Increased levels of cyclic adenosine monophosphate (cAMP) are associated with the activation of certain receptors, such as beta-adrenergic receptors. cAMP generally leads to relaxation of smooth muscle, but sodium nitroprusside's mechanism is mediated through cGMP. Option C - Calcium channel blockage : Sodium nitroprusside does not directly block calcium channels. Its mechanism is centered around the stimulation of guanylyl cyclase and the subsequent increase in cGMP levels, leading to vasodilation. Option D - K + channel opener : Sodium nitroprusside does not directly open potassium (K + ) channels. Its primary effect is on guanylyl cyclase, which increases cGMP levels and promotes vasodilation. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 52,
      "question": "What is the mechanism of action of sacubitril, a newly approved drug for the treatment of chronic heart failure?",
      "options": {
        "A": "Angiotensin II inhibitor",
        "B": "ACE inhibitor",
        "C": "Renin inhibitor",
        "D": "Neutral endopeptidase inhibitor"
      },
      "correct_answer": "D",
      "explanation": "also known as a neprilysin inhibitor . It is used in the treatment of chronic heart failure. The mechanism of action of sacubitril involves inhibiting the enzyme neprilysin, which is responsible for the degradation of several vasoactive peptides, including natriuretic peptides, bradykinin, and adrenomedullin. By inhibiting neprilysin, sacubitril increases the levels of these vasoactive peptides, leading to vasodilation, diuresis, and natriuresis. This helps to reduce the workload on the heart and improve cardiac function in patients with heart failure. Incorrect Options: Option A - Angiotensin II inhibitor: Angiotensin II inhibitors, also known as angiotensin receptor blockers (ARBs), work by blocking the action of angiotensin II, a hormone that constricts blood vessels and promotes water and salt retention. They are commonly used in the treatment of hypertension and heart failure, but sacubitril is not an angiotensin II inhibitor. Option B - ACE inhibitor: ACE inhibitors, or angiotensin-converting enzyme inhibitors, block the enzyme ACE, which converts angiotensin I to angiotensin II. Sacubitril is not an ACE inhibitor. Option C - Renin inhibitor: Renin inhibitors target the enzyme renin, which plays a key role in the production of angiotensin II. By inhibiting renin, these drugs reduce the production of angiotensin II and help lower blood pressure. However, sacubitril is not a renin inhibitor. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 53,
      "question": "Which of the following drugs is associated with QT prolongation ?",
      "options": {
        "A": "Lignocaine",
        "B": "Quinidine",
        "C": "Magnesium sulfate",
        "D": "All of the above"
      },
      "correct_answer": "B",
      "explanation": "prolongation, along with other cardiac rhythm abnormalities. It is known to have a potential proarrhythmic effect. Incorrect Options: Option A - Lignocaine: Lignocaine (also known as Lidocaine) is a local anesthetic and is not typically associated with significant QT prolongation. It can shorten the QT interval. Option C - Magnesium sulfate: Magnesium sulfate is commonly used in the treatment of certain cardiac arrhythmias and is not typically associated with significant QT prolongation. Option D - All of the above: Lignocaine and magnesium sulfate are not strongly associated with QT prolongation. Only quinidine is known for its potential to prolong the QT interval. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 54,
      "question": "A patient who is on treatment for angina, presents to you with erectile dysfunction. You decide against prescribing sildenafil because the patient is being treated with ____________:",
      "options": {
        "A": "Calcium channel blockers",
        "B": "Beta blockers",
        "C": "Nitrates",
        "D": "ACE inhibitors"
      },
      "correct_answer": "C",
      "explanation": "treatment of angina. Sildenafil, the medication used for erectile dysfunction, should not be prescribed concomitantly with nitrates. Both medications can cause a significant drop in blood pressure when used together, leading to a potentially dangerous condition called hypotension. Therefore, nitrates are the correct option for the given scenario. Incorrect Options: Option A - Calcium channel blockers: Calcium channel blockers are commonly used in the treatment of angina to relax and widen the blood vessels, reducing the workload on the heart and improving blood flow. They are generally not contraindicated with sildenafil, the medication used to treat erectile dysfunction. Therefore, calcium channel blockers are an incorrect option for the given scenario. Option B - Beta blockers: Beta blockers are another class of medications commonly used to treat angina. They work by reducing the heart rate and blood pressure. While beta blockers can potentially contribute to erectile dysfunction, they are not an absolute contraindication for sildenafil use. In fact, sildenafil can be prescribed cautiously in patients taking beta blockers under appropriate medical supervision. Therefore, beta blockers are an incorrect option for the given scenario. Option D - ACE inhibitors: ACE inhibitors are a class of medications commonly used to treat high blood pressure and heart failure. They do not typically cause significant interactions or contraindications with sildenafil. Therefore, ACE inhibitors are an incorrect option for the given scenario. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 55,
      "question": "Which of the following drugs causes activation of K+-ATP channels ?",
      "options": {
        "A": "Nicorandil",
        "B": "Molsidomine",
        "C": "Isosorbide dinitrate",
        "D": "Nitroglycerin"
      },
      "correct_answer": "A",
      "explanation": "ATP-sensitive potassium (K+-ATP) channels. It is a hybrid compound that combines nitrate-like properties with potassium channel activation effects. By activating K+-ATP channels, Nicorandil promotes arterial and venous dilation , leading to decreased vascular resistance and increased blood flow. It is primarily used in the treatment of angina pectoris. Incorrect Options: Option B - Molsidomine : Molsidomine is a nitric oxide donor that primarily works by releasing nitric oxide, leading to vasodilation. However, it does not directly activate K+-ATP channels. Option C - Isosorbide dinitrate: Isosorbide dinitrate is a nitrate medication that acts as a vasodilator. It primarily works by releasing nitric oxide, which relaxes smooth muscles and dilates blood vessels. Option D - Nitroglycerin : Nitroglycerin is also a nitrate medication that acts as a vasodilator by releasing nitric oxide. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 56,
      "question": "A hypertensive patient was started on some anti-hypertensive drug but he developed a dry cough . Which of the following drug can be responsible for this effect?",
      "options": {
        "A": "Calcium channel blockers",
        "B": "Beta blockers",
        "C": "ACE inhibitors",
        "D": "Diuretics"
      },
      "correct_answer": "C",
      "explanation": "class of medications commonly prescribed for hypertension. They work by blocking the action of angiotensin-converting enzyme, which converts angiotensin I to angiotensin II, a potent vasoconstrictor. Dry cough is a well-known and relatively common side effect of ACE inhibitors, occurring in up to 10% of patients. The cough is thought to be due to an increase in bradykinin levels caused by ACE inhibition. Incorrect Options: Option A - Calcium channel blockers: Calcium channel blockers (CCBs) are a class of medications commonly used to treat hypertension. They work by blocking calcium channels in smooth muscle cells, leading to vasodilation and a reduction in blood pressure. Dry cough is not a common side effect associated with calcium channel blockers. Option B - Beta-blockers: Beta-blockers are another class of medications used to treat hypertension. They work by blocking the effects of adrenaline (epinephrine) on beta receptors, resulting in decreased heart rate and blood pressure. While beta-blockers can cause side effects such as fatigue, dizziness, and sexual dysfunction, dry cough is not typically associated with this class of drugs. Option D - Diuretics: Diuretics, also known as water pills, are frequently used as a first-line treatment for hypertension. They work by increasing the excretion of sodium and water from the body, resulting in reduced blood volume and lower blood pressure. Dry cough is not a commonly reported side effect of diuretics. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 57,
      "question": "A 44-year-old male was admitted to the ICU after being diagnosed with Subarachnoid hemorrhage secondary to a ruptured aneurysm . The patient is a known case of stage 2 hypertension and was taking Ramipril for the same. Which of the following calcium channel blockers can be used in this case, which might help relieve the cerebral vasospasm?",
      "options": {
        "A": "Nimodipine",
        "B": "Felodipine",
        "C": "Amlodipine",
        "D": "Nitrendipine"
      },
      "correct_answer": "A",
      "explanation": "the prevention and treatment of cerebral vasospasm following subarachnoid hemorrhage (SAH). It has a selective action on cerebral blood vessels, dilating them and improving blood flow in the brain. Nimodipine is the drug of choice for treating vasospasm in this context due to its specific action on cerebral arteries. Incorrect Options: Option B - Felodipine: Felodipine is a calcium channel blocker that primarily acts on peripheral blood vessels, resulting in vasodilation and reduced systemic vascular resistance. It is mainly used for the treatment of hypertension. However, felodipine does not have a specific indication for the treatment of cerebral vasospasm following SAH. Option C - Amlodipine: Amlodipine is a calcium channel blocker that acts primarily on peripheral blood vessels, similar to felodipine. It is widely used for the treatment of hypertension and angina pectoris. While amlodipine may have some vasodilatory effects on cerebral blood vessels, it does not have a specific indication for the treatment of cerebral vasospasm following SAH. Option D - Nitrendipine: Nitrendipine is another calcium channel blocker that primarily acts on peripheral blood vessels, leading to vasodilation. It is commonly used for the treatment of hypertension. However, like felodipine and amlodipine, it does not have a specific indication for the treatment of cerebral vasospasm. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 58,
      "question": "Drug of choice for paroxysmal supraventricular tachycardia is:",
      "options": {
        "A": "Digoxin",
        "B": "Propranolol",
        "C": "Adenosine",
        "D": "Dilitiazem"
      },
      "correct_answer": "C",
      "explanation": "potent and rapidly acting medication that is administered intravenously during an episode of PSVT. Adenosine works by temporarily blocking the electrical conduction in the heart, thereby interrupting the abnormal circuit responsible for PSVT. The use of adenosine results in a brief pause in the heart rhythm, followed by restoration of normal sinus rhythm in most cases. Incorrect Options: Option A - Digoxin: Digoxin is a medication commonly used to treat heart failure and certain arrhythmias. However, it is not typically the drug of choice for acute episodes of PSVT. Digoxin has a slower onset of action and is more commonly used for long-term management of certain types of arrhythmias. Option B - Propranolol: Propranolol is a beta-blocker that can be effective in managing various types of tachycardia, including PSVT. It works by blocking the effects of adrenaline on the heart, thereby slowing down the heart rate. While propranolol may be used in some cases of PSVT, it is not considered the first-line drug of choice for acute termination of an episode. Option D - Diltiazem: Diltiazem is a calcium channel blocker that can also be used in the management of PSVT. It works by reducing the influx of calcium into the heart muscle cells, leading to a decrease in heart rate and contractility. Diltiazem is commonly used in cases where adenosine is contraindicated or ineffective. It is particularly useful in patients with underlying cardiovascular conditions, such as hypertension or coronary artery disease. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 59,
      "question": "Preferred drug for the treatment of ventricular tachycardia is:",
      "options": {
        "A": "Digoxin",
        "B": "Propranolol",
        "C": "Diltiazem",
        "D": "Lignocaine"
      },
      "correct_answer": "D",
      "explanation": "preferred drug for the treatment of ventricular tachycardia, a condition characterized by rapid, abnormal heart rhythms originating from the ventricles. It is administered intravenously for its antiarrhythmic effects. Incorrect Options: Option A - Digoxin: Digoxin is primarily used for the treatment of heart failure and certain arrhythmias but is not the preferred drug for ventricular tachycardia. Option B - Propranolol: Propranolol is a beta-blocker medication used for various cardiovascular conditions, including arrhythmias. While it can be used for certain types of arrhythmias, other antiarrhythmic drugs like Lignocaine are preferred for ventricular tachycardia. Option C - Diltiazem: Diltiazem is a calcium channel blocker used for the treatment of hypertension and certain heart rhythm disorders, but it is not typically the preferred drug for ventricular tachycardia. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 60,
      "question": "What medications should be administered to manage a patient who is 34 weeks pregnant and experiencing seizures, with a blood pressure reading of 200/110 mmHg?",
      "options": {
        "A": "Oral Labetalol",
        "B": "IV labetalol plus magnesium sulphate",
        "C": "IV Lorazepam",
        "D": "IV Enalapril"
      },
      "correct_answer": "B",
      "explanation": "labetalol and magnesium sulfate is commonly used in the management of severe hypertension and seizures associated with preeclampsia or eclampsia. Labetalol is a beta-blocker that helps lower blood pressure by blocking the effects of certain stress hormones on the heart and blood vessels. Magnesium sulfate is an anticonvulsant medication that helps prevent and control seizures in women with preeclampsia or eclampsia. Incorrect Options: Option A - Oral Labetalol: Oral Labetalol alone may not be sufficient for immediate control of severe hypertension and seizure activity in this critical situation. IV administration allows for rapid onset of action. Option C - IV Lorazepam: IV Lorazepam is a sedative and anti-anxiety medication but is not the first-line treatment for severe hypertension and seizures associated with preeclampsia or eclampsia. Option D - IV Enalapril: IV Enalapril is an angiotensin-converting enzyme (ACE) inhibitor and is contraindicated during pregnancy due to potential harm to the fetus, especially in the presence of severe hypertension and organ dysfunction. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 61,
      "question": "Which of the following is not used in heart failure ?",
      "options": {
        "A": "Trimetazidine",
        "B": "Sacubitril",
        "C": "Metoprolol",
        "D": "Nesiritide"
      },
      "correct_answer": "A",
      "explanation": "failure. It is primarily used in the treatment of angina pectoris and ischemic heart disease. Trimetazidine acts by improving myocardial glucose utilization and reducing fatty acid oxidation, which helps in preserving cardiac energy metabolism. However, it does not have direct effects on heart failure pathophysiology, such as reducing preload or afterload, improving cardiac contractility, or inhibiting neurohormonal activation, which are important therapeutic targets in heart failure. Incorrect Options: Option B - Sacubitril: Sacubitril is a neprilysin inhibitor used in the management of heart failure with reduced ejection fraction (HFrEF). It is combined with the angiotensin receptor blocker (ARB) valsartan to form sacubitril/valsartan, which has been shown to reduce cardiovascular mortality and hospitalizations in HFrEF patients. Option C - Metoprolol: Metoprolol is a beta-blocker commonly used in the treatment of heart failure. It helps in reducing heart rate, blood pressure, and cardiac workload, thereby improving symptoms and outcomes in heart failure patients. Option D - Nesiritide: Nesiritide is a recombinant form of human B-type natriuretic peptide (BNP) used in acute decompensated heart failure. It has vasodilatory and diuretic effects, leading to decreased preload and afterload, improved cardiac output, and relief of symptoms in acute heart failure episodes. However, its long-term use in chronic heart failure is limited. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 62,
      "question": "A 53 year old man is found to have stage 2 hypertension without any co morbidities . Which drug will you start ?",
      "options": {
        "A": "Furosemide",
        "B": "Chlorthalidone",
        "C": "Spironolactone",
        "D": "Triamterene"
      },
      "correct_answer": "B",
      "explanation": "co-morbidities, the preferred initial medication would be a thiazide-like diuretic. Chlorthalidone , which belongs to the thiazide class of diuretics, is an appropriate choice. Thiazide diuretics, such as, Chlorthalidone are considered first-line agents for treating hypertension due to their proven efficacy and safety profile. They help lower blood pressure by promoting diuresis (increased urine production) and reducing fluid volume in the body. This results in a decrease in systemic vascular resistance and blood pressure. Incorrect Options: Option A - Furosemide: Furosemide is a loop diuretic, which is more potent than thiazide diuretics. They are not usually the first-line choice for uncomplicated hypertension. Option C - Spironolactone: Spironolactone is a potassium-sparing diuretic and is often used as an adjunct therapy in cases where additional blood pressure control is needed. It is not typically used as monotherapy for initial treatment of hypertension. Option D - Triamterene: Triamterene is another potassium-sparing diuretic commonly used in combination with other diuretics to reduce potassium loss. It is not typically used as monotherapy for initial treatment of hypertension. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 63,
      "question": "Which of the following drugs does not reduce mortality in patients with heart failure with reduced ejection fraction (HFrEF)?",
      "options": {
        "A": "Digoxin",
        "B": "Beta-blockers",
        "C": "ACE inhibitors",
        "D": "Hydralazine + isosorbide dinitrate"
      },
      "correct_answer": "A",
      "explanation": "condition in which the heart cannot pump enough blood to meet the body's needs. Several drugs have been shown to improve symptoms and reduce mortality in patients with HFrEF. Digoxin is a medication used for many years to treat heart failure. While it can improve symptoms such as shortness of breath and fatigue, it has not been shown to reduce mortality in patients with HFrEF. However, digoxin may still have a role in managing symptoms in certain patients with HFrEF. Incorrect Options: Option B - Beta-blockers: Beta-blockers such as metoprolol, carvedilol, and bisoprolol are among the most effective medications for treating HFrEF. They work by reducing the workload on the heart and improving its pumping ability. Beta-blockers have been shown to reduce mortality by about 30% in patients with HFrEF. Option C - ACE inhibitors: ACE inhibitors such as lisinopril, enalapril, and ramipril are another class of effective drugs in treating HFrEF. They work by dilating blood vessels and reducing the workload on the heart. ACE inhibitors have been shown to reduce mortality by about 20-25% in patients with HFrEF. Option D - Hydralazine + isosorbide dinitrate: Hydralazine + isosorbide dinitrate, sometimes used in patients with HFrEF who cannot tolerate ACE inhibitors or angiotensin receptor blockers (ARBs). Hydralazine is a vasodilator that relaxes blood vessels, while isosorbide dinitrate is a nitrate that also dilates blood vessels. This combination has reduced mortality by about 25% in African-American patients with HFrEF. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cvs Pharmacology-Previous Year Questions"
    }
  ]
}
